AXIAL SPONDYLOARTHRITIS (AXSPA)
Clinical trials for AXIAL SPONDYLOARTHRITIS (AXSPA) explained in plain language.
Never miss a new study
Get alerted when new AXIAL SPONDYLOARTHRITIS (AXSPA) trials appear
Sign up with your email to follow new studies for AXIAL SPONDYLOARTHRITIS (AXSPA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to tame back and joint inflammation
Disease control Recruiting nowThis study tests an experimental pill called GRWD0715 for people with axial spondyloarthritis, a condition that causes long-term inflammation in the spine and pelvic joints. The trial starts with healthy volunteers to check safety, then moves to patients to see if the drug reduce…
Matched conditions: AXIAL SPONDYLOARTHRITIS (AXSPA)
Phase: PHASE1, PHASE2 • Sponsor: Grey Wolf Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Can you take less medicine and still control arthritis? new study aims to find out
Disease control Recruiting nowThis study tests whether people with rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis who are doing well on a JAK inhibitor can safely lower their dose without losing disease control. About 200 participants will either follow a guided dose-reduction plan or c…
Matched conditions: AXIAL SPONDYLOARTHRITIS (AXSPA)
Phase: PHASE4 • Sponsor: Sint Maartenskliniek • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Yoga vs. physio: new study tests which eases arthritis pain best
Symptom relief Recruiting nowThis study compares yoga therapy to standard physiotherapy for people with moderate axial spondyloarthritis, a type of arthritis that causes back pain and stiffness. Researchers want to see if yoga can improve physical symptoms like pain and fatigue, as well as mental well-being.…
Matched conditions: AXIAL SPONDYLOARTHRITIS (AXSPA)
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated May 17, 2026 05:30 UTC